Understanding the chemical nuances of pharmaceutical intermediates is fundamental to their effective utilization. Dexrazoxane, bearing the CAS number 24584-09-6, is a compound that commands attention due to its specific chemical profile and crucial role in medicine.

Chemically, Dexrazoxane is known by various synonyms such as (S)-4,4'-(1-Methyl-1,2-ethanediyl)bis-2,6-piperazinedione. Its molecular formula is C11H16N4O4, with a molecular weight of approximately 268.27 g/mol. This structure dictates its function as an iron chelator, which is key to its primary application as a cardioprotective agent against the toxicity of anthracyclines in cancer therapy. The compound's physical form is typically described as a white to off-white powder.

The safety data associated with Dexrazoxane, including hazard statements like 'Causes skin irritation' (H315), 'Causes serious eye irritation' (H319), and 'May cause respiratory irritation' (H335), highlights the importance of proper handling and adherence to precautionary statements (e.g., P261, P305+P351+P338). For researchers and manufacturers, obtaining this compound from a reliable supplier in China ensures that the material meets established purity specifications, vital for both R&D and clinical applications.

As a significant pharmaceutical intermediate, Dexrazoxane is more than just a chemical entity; it represents a critical step in producing life-saving therapies. Its well-defined chemical properties, coupled with its therapeutic benefits, make it a compound of continuous interest in the pharmaceutical industry. Access to detailed chemical information and a secure supply chain for intermediates like Dexrazoxane (CAS 24584-09-6) is essential for driving medical innovation forward.